Sign In

Willem Baralt

Chair | Board Member – driven to grow companies by developing sustainable strategies, fundraising and building strong teams.

Willem Baralt was recently appointed as the new Chairman of the Board at Synthace, a leading digital experiment platform for life science R&D.1 Here are some key details about Willem Baralt:

Professional Background

  • Appointed Chairman of Synthace in February 20241
  • Previously served as Chief Financial Officer at Quanta Dialysis Technologies from 2014 to 20222
  • Played a crucial role in leading Quanta Dialysis Technologies through FDA clearance and commercialization1
  • Oversaw several funding rounds at Quanta, including securing a $245 million Series D round, the largest private dialysis company raise in history1

Experience and Expertise

  • Accomplished Non-Executive Board Director and Chairman1
  • Extensive experience in:
    • Driving commercial growth
    • Devising sustainable strategies
    • Fundraising
    • Overseeing M&A activities
    • Fostering teams1

Current Roles

  • Serves on the boards of various private healthcare firms and charitable organizations1
  • Chairman of the Board at Synthace (since February 2024)2

Notable Achievements

  • Guided Flag Telecom through a NASDAQ IPO1
  • Facilitated numerous M&A transactions and restructures1

LinkedIn Profile

Willem Baralt's LinkedIn username is wgbhome.3

Willem Baralt's appointment comes at a time when Synthace is experiencing accelerating growth and expanding its offerings. His expertise is expected to help Synthace integrate AI capabilities with its digital experimentation platform, potentially revolutionizing the R&D landscape in the life sciences industry.1

Highlights

Aug 30 · linkedin

Excited to share that I will be speaking at the LSX World Congress USA in Boston on September 11th-12th, 2024! Join me and a distinguished panel of experts as we delve into the foundations of successful payer relationships in the Medtech industry. I'm looking forward to insightful discussions alongside Georgia Mitsi, Christian Howell, Carolina Aguilar, and Chris Springate.

#Medtech #HealthTech #Biotech #LSXWorldCongress #PayerRelationships #Synthace #Biorce #Adaptix #Eversens

Apr 29 · linkedin

I'm excited to announce that I'll be speaking at EMERGE 2050, the Dubai healthcare conference on May 8-9th.

If you're attending, let's connect and exchange views. I will also be sharing some insights on the companies I work with: Synthace, Adaptix Ltd, EVERSENS SL , and BIORCE.

Be a part of EMERGE 2050! Register : https://lnkd.in/dxSCwHt4

#emerge2050 #healthtech #medtech #biotech #healthcareinnovations #familyoffice #superreturn #superventure #vc #venturecapital #healthcare #lifesciences #digitalhealth #CorporateGovernance

Related Questions

What are Willem Baralt's key achievements at Quanta Dialysis Technologies?
How did Willem Baralt contribute to Flag Telecom's NASDAQ IPO?
What specific strategies does Willem Baralt plan to implement at Synthace?
How does Willem Baralt's experience in M&A transactions benefit Synthace?
What are Willem Baralt's views on the future of digital experimentation in life sciences?
Willem Baralt
Willem Baralt, photo 1
Willem Baralt, photo 2
Add to my network

Location

London Area, United Kingdom